• Home
  • Consortium
    • Beneficiary 1 (coordinator): IBEC
    • Beneficiary 2: TUE
    • Beneficiary 3: GRO
    • Beneficiary 4: BAS
    • Beneficiary 5: EDI
    • Beneficiary 6: TAU
    • Beneficiary 7: TEVA
    • Beneficiary 8: TAG
    • Beneficiary 9: BGX
    • Partner Organisation 1: CRUK
    • Partner Organisation 2: ESADE
    • Partner Organisation 3: UAB
  • Project Summary
  • Training events
  • Jobs
  • Fellows
    • ESR1 – Michela Vargiu (GRO)
    • ESR2 – Shreyas Wagle (TAU)
    • ESR3 – Krishna Vippala (TEVA)
    • ESR4 – Anjana Sathyan (TUE)
    • ESR5 – Stephen Croke (EDI)
    • ESR6 – Emmanouil Archontakis (TUE)
    • ESR7 – Alis Olea (IBEC)
    • ESR8 – Linlin Deng (TUE)
    • ESR9 – África Gálvez Flores (BGX/IBEC)
    • ESR10 – Boris Lozhkin (BAS)
    • ESR11 – Melissa van de L’Isle (EDI)
    • ESR12 – Maria Vlastara (TAG)
    • ESR13 – Daniel Rodriguez (TAU)
  • Communication
THERACAT
Saltar al contenido
  • Home
  • Consortium
    • Beneficiary 1 (coordinator): IBEC
    • Beneficiary 2: TUE
    • Beneficiary 3: GRO
    • Beneficiary 4: BAS
    • Beneficiary 5: EDI
    • Beneficiary 6: TAU
    • Beneficiary 7: TEVA
    • Beneficiary 8: TAG
    • Beneficiary 9: BGX
    • Partner Organisation 1: CRUK
    • Partner Organisation 2: ESADE
    • Partner Organisation 3: UAB
  • Project Summary
  • Training events
  • Jobs
  • Fellows
    • ESR1 – Michela Vargiu (GRO)
    • ESR2 – Shreyas Wagle (TAU)
    • ESR3 – Krishna Vippala (TEVA)
    • ESR4 – Anjana Sathyan (TUE)
    • ESR5 – Stephen Croke (EDI)
    • ESR6 – Emmanouil Archontakis (TUE)
    • ESR7 – Alis Olea (IBEC)
    • ESR8 – Linlin Deng (TUE)
    • ESR9 – África Gálvez Flores (BGX/IBEC)
    • ESR10 – Boris Lozhkin (BAS)
    • ESR11 – Melissa van de L’Isle (EDI)
    • ESR12 – Maria Vlastara (TAG)
    • ESR13 – Daniel Rodriguez (TAU)
  • Communication

Consortium

BENEFICIARIES Dept./Division/Lab Country Scientist-in-charge
Institute for Bioengineering of Catalonia (IBEC) Nanoscopy for nanomedicine group Spain Lorenzo Albertazzi
Technische Universiteit Eindhoven (TUE) Macromolecular and Organic chemistry laboratory Netherlands Anja Palmans
Rijksuniversiteit Groningen (GRO) Biomolecular Chemistry & Catalysis group Netherlands Gerard Roefles
Universität Basel (BAS) Artificial Metalloenzymes laboratory Switzerland Thomas Ward
University of Edinburgh (EDI) Innovative Therapeutics laboratory United Kingdom Asier Unciti-Broceta
Tel Aviv University (TAU) Prof. Satchi-Fainaro’s laboratory
Dr. Amir group
Israel Ronit Satchi-Fainaro & Roey Amir
TEVA Pharmaceutical Industries Ltd. (TEVA) Israel Bianca Avramovitch
Tagworks Pharmaceuticals BV (TAG) Netherlands Marc Robillard
Biogelx Limited (BGX) United Kingdom Laura Goldie
Partner organisations Country
Cancer Research UK (CRUK) United Kingdom
Fundación ESADE (ESADE) Spain
Universitat Autònoma de Barcelona (UAB) Spain
https://youtu.be/zpEygq-vNr8

THERACAT Conference

THERACAT Conference
Barcelona, 1st July

Please follow & like us :)

Twitter

Private access

  • Acceder

Project Information

THERACAT
Bio-orthogonal catalysis for cancer therapy

MSCA-ITN-2017
European Training Networks
Project ID: 765497
From 2018-03-01 to 2022-08-31
CORDIS Link

Contact

Coordinator: Dr. Lorenzo Albertazzi
Nanoscopy for nanomedicine Group
Institute for Bioengineering of Catalonia
Tel: +34 934 020 517

© IBEC 2018
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 765497
ZeroGravity por GalussoThemes.com
Funciona con WordPress
Social Share Buttons and Icons powered by Ultimatelysocial